Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids

被引:53
作者
Dinari, Mohammad [1 ]
Gharahi, Fateme [1 ]
Asadi, Parvin [2 ]
机构
[1] Isfahan Univ Technol, Dept Chem, Esfahan 8415683111, Iran
[2] Isfahan Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Med Chem, Esfahan 8174673461, Iran
关键词
s-Triazine; Antimicrobial agents; Docking simulation; Quinazolinone; Hybrids; ANTICANCER ACTIVITY; DNA INTERACTION; DERIVATIVES; DESIGN; PHARMACOPHORE; INHIBITORS; BENZIMIDAZOLE; BEARING; BINDING;
D O I
10.1016/j.molstruc.2017.11.087
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A new series of 1,3,5-triazine incorporating aromatic quinazolinone moieties as a potential antimicrobial agents is reported. The first chlorine group of the cyanuric chloride (1) was replaced by aniline and the second one was replaced by various aromatic amines. The prepared monochlorotriazine was allowed to react with hydrazine and subsequently it was reacted with 2-methyl-4H-benzo[1,3]oxazin-4-one to obtain novel triazine-quinazolinone based hybrids (9a-f). The chemical structure and purity of the hybrid compounds were evaluated by different techniques such as thin layer chromatography, melting point, Fourier-transform infrared (FTIR), H-1 and C-13 NMR spectra and elemental analysis. Antimicrobial activity of the hybrid compounds were study by three Gram-negative bacteria (Salmonella entritidis, Escherichia coli, Pseudomonas aeruginosa) and three Gram-positive bacteria (Staphylococcus aureus, Listeria monocitogenes, Bacillus subtilis) as well as Candida albicansas a yeast-like fungus using the serial broth dilution method. Among them, compound 9d with benzenesulfonamide group showed higher antimicrobial activity with a minimum inhibitory concentration (MIC) value of 16 mu g/mL. Furthermore, compounds 5d, 9a and 9b showed good activity against several tested strains. In addition, docking simulation was perform to position best antibacterial compounds in to the S. aureus dihydrofolate reductase (DHFR) active site to determine the probable binding conformations. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 37 条
[1]   Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach [J].
Addla, Dinesh ;
Bhima ;
Sridhar, Balasubramanian ;
Devi, Anjana ;
Kantevari, Srinivas .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) :7475-7480
[2]  
Asadi P., 2017, CHEM BIODIVERS, V14, P1
[3]  
Bender D. A., 1984, CHEM BIOCH FOLATES, VI, P115
[4]   Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives [J].
Bhat, Hans Raj ;
Singh, Udaya Pratap ;
Yadav, Pankaj S. ;
Kumar, Vikas ;
Gahtori, Prashant ;
Das, Aparoop ;
Chetia, Dipak ;
Prakash, Anil ;
Mahanta, J. .
ARABIAN JOURNAL OF CHEMISTRY, 2016, 9 :S625-S631
[5]  
BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126
[6]   Fabrication and characterization of hybrid films based on polyaniline and graphitic carbon nitride nanosheet [J].
Dinari M. ;
Momeni M.M. ;
Afshari M. .
Journal of Applied Polymer Science, 2016, 133 (40)
[7]   Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors [J].
Farag, Doaa Boshra ;
Farag, Nahla A. ;
Esmat, Ahmed ;
Abuelezz, Sally A. ;
Ibrahim, Eman Abdel-Salam ;
Abou El Ella, Dalal A. .
MEDCHEMCOMM, 2015, 6 (02) :283-299
[8]   Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids [J].
Ghorab, Mostafa M. ;
Alsaid, Mansour S. ;
Al-Dosari, Mohammed S. ;
El-Gazzar, Marwa G. ;
Parvez, Mohammad K. .
MOLECULES, 2016, 21 (02)
[9]   Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety [J].
Ghorab, Mostafa M. ;
Ismail, Zienab H. ;
Radwan, Awwad A. ;
Abdalla, Mohamad .
ACTA PHARMACEUTICA, 2013, 63 (01) :1-18
[10]   Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents [J].
Giri, Rajan S. ;
Thaker, Hardik M. ;
Giordano, Tony ;
Williams, Jill ;
Rogers, Donna ;
Sudersanam, Vasudevan ;
Vasu, Kamala K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) :2184-2189